Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.600
-0.032 (-5.02%)
At close: Feb 27, 2026, 4:00 PM EST
0.603
+0.003 (0.53%)
After-hours: Feb 27, 2026, 7:11 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $29.13 million as of February 27, 2026. Its market cap has decreased by -56.99% in one year.
Market Cap
29.13M
Enterprise Value
722.83K
1-Year Change
-56.99%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $29.13M, a decrease of -93.38%. That is a compound annual growth rate of -42.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 29.13M | -5.26% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 31.54M |
| Tempest Therapeutics | 30.74M |
| NeuroSense Therapeutics | 30.35M |
| AN2 Therapeutics | 30.14M |
| Rein Therapeutics | 29.97M |
| Passage Bio | 28.99M |
| AEON Biopharma | 28.34M |
| Dyadic International | 28.19M |